This Amendment No. 2 (this “Final Amendment”) relates to the Issuer Tender Offer Statement on Schedule TO originally filed on July 9, 2021, as amended and supplemented by Amendment No. 1 to the Issuer Tender Offer Statement on Schedule TO filed on July 28, 2021 (together, the “Schedule TO”), by BlackRock Multi-Sector Opportunities Trust (the “Trust”), pursuant to Rule 13e-4 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in connection with an offer by the Trust (the “Offer”) to repurchase 2.5% of its issued and outstanding common shares of beneficial interest, par value $0.001 per share (the “Shares”), in exchange for cash at a price equal to the net asset value per Share determined as of the close of the regular trading session of the New York Stock Exchange on the day the Offer expires, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated July 9, 2021 (the “Original Offer to Purchase”), as amended and supplemented by the Supplement No. 1 to the Offer to Purchase, dated July 28, 2021 (the “Supplement” and together with the Original Offer to Purchase, the “Offer to Purchase”), and in the related Letter of Transmittal, copies of which were previously filed as exhibits to the Schedule TO.
This is the Final Amendment to the Schedule TO and is being filed to report the results of the Offer. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Offer to Purchase or the Schedule TO.
The following information is furnished to satisfy the requirements of Rule 13e-4(c)(4) under the Exchange Act:
| 1. | The Offer expired at 5:00 p.m. Eastern time, on August 25, 2021. |
| 2. | 131,180 Shares of the Trust were validly tendered and not withdrawn prior to the expiration of the Offer, and 98,133 of those Shares were accepted for repurchase by the Trust in accordance with the terms of the Offer. |
| 3. | The Shares were repurchased at a price of $89.46. |
Except as specifically provided herein, the information contained in the Schedule TO, the Offer to Purchase and the Letter of Transmittal remains unchanged and this Final Amendment does not modify any of the information previously reported in the Schedule TO, the Offer to Purchase or the Letter of Transmittal.
Item 1 through Item 9 and Item 11.
The information set forth in the Offer to Purchase (as amended by the Supplement) and the related Letter of Transmittal is incorporated herein by reference into this Final Amendment in answer to Item 1 through Item 9 and Item 11 of Schedule TO.
Item 10. | Financial Statements |
Not applicable.
Item 12 of the Schedule TO is hereby amended and supplemented to add the following exhibit:
(a)(5)(iii) Press release issued on August 26, 2021 is filed herewith.
Item 13. | Information Required By Schedule 13E-3 |
Not applicable.